Fresenius Medical Care AG & Co. (Pref) (FME) Given a €83.00 Price Target by Deutsche Bank Analysts

Fresenius Medical Care AG & Co. (Pref) (ETR:FME) received a €83.00 ($98.81) price target from research analysts at Deutsche Bank in a research note issued to investors on Monday. The firm currently has a “neutral” rating on the stock. Deutsche Bank’s price objective would indicate a potential downside of 9.03% from the stock’s current price.

Several other equities analysts also recently weighed in on the company. Commerzbank set a €87.00 ($103.57) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research report on Wednesday, January 10th. JPMorgan Chase & Co. set a €95.60 ($113.81) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “buy” rating in a research report on Wednesday, January 10th. Independent Research set a €90.00 ($107.14) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research report on Thursday, January 4th. UBS Group set a €87.00 ($103.57) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research report on Thursday, January 4th. Finally, Morgan Stanley set a €90.00 ($107.14) target price on Fresenius Medical Care AG & Co. (Pref) and gave the company a “neutral” rating in a research report on Monday, December 11th. Ten equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of €90.17 ($107.34).

Fresenius Medical Care AG & Co. (ETR FME) opened at €91.24 ($108.62) on Monday. The firm has a market capitalization of $28,110.00 and a PE ratio of 22.36. Fresenius Medical Care AG & Co. has a 52-week low of €74.43 ($88.61) and a 52-week high of €92.50 ($110.12).

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/22/fresenius-medical-care-ag-83-00-price-target-by-deutsche-bank-analysts.html.

About Fresenius Medical Care AG & Co. (Pref)

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply